395 related articles for article (PubMed ID: 33402117)
1. EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function.
Joly-Tonetti N; Ondet T; Monshouwer M; Stamatas GN
BMC Cancer; 2021 Jan; 21(1):5. PubMed ID: 33402117
[TBL] [Abstract][Full Text] [Related]
2. Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients.
Paul T; Schumann C; Rüdiger S; Boeck S; Heinemann V; Kächele V; Steffens M; Scholl C; Hichert V; Seufferlein T; Stingl JC
Eur J Cancer; 2014 Jul; 50(11):1855-63. PubMed ID: 24857781
[TBL] [Abstract][Full Text] [Related]
3. The potential use of protein kinase D inhibitors for prevention/treatment of epidermal tumors.
Arun SN; Xie D; Dodd ME; Zhong X; Bollag WB
J Dermatol Sci; 2010 Oct; 60(1):29-39. PubMed ID: 20832999
[TBL] [Abstract][Full Text] [Related]
4. The receptor tyrosine kinase ERBB4 is expressed in skin keratinocytes and influences epidermal proliferation.
Hoesl C; Röhrl JM; Schneider MR; Dahlhoff M
Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):958-966. PubMed ID: 29410073
[TBL] [Abstract][Full Text] [Related]
5. Unlocking the Mechanisms of Cutaneous Adverse Drug Reactions: Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway by EGFR Inhibitors Triggers Keratinocyte Differentiation and Polarization of Epidermal Immune Responses.
Ondet T; Roux PF; Monshouwer M; Stamatas GN
JID Innov; 2021 Jun; 1(2):100009. PubMed ID: 34909713
[TBL] [Abstract][Full Text] [Related]
6. TRPV3 enhances skin keratinocyte proliferation through EGFR-dependent signaling pathways.
Wang Y; Li H; Xue C; Chen H; Xue Y; Zhao F; Zhu MX; Cao Z
Cell Biol Toxicol; 2021 Apr; 37(2):313-330. PubMed ID: 32535744
[TBL] [Abstract][Full Text] [Related]
7. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation.
Franzke CW; Cobzaru C; Triantafyllopoulou A; Löffek S; Horiuchi K; Threadgill DW; Kurz T; van Rooijen N; Bruckner-Tuderman L; Blobel CP
J Exp Med; 2012 Jun; 209(6):1105-19. PubMed ID: 22565824
[TBL] [Abstract][Full Text] [Related]
8. Selective matrix (hyaluronan) interaction with CD44 and RhoGTPase signaling promotes keratinocyte functions and overcomes age-related epidermal dysfunction.
Bourguignon LY; Wong G; Xia W; Man MQ; Holleran WM; Elias PM
J Dermatol Sci; 2013 Oct; 72(1):32-44. PubMed ID: 23790635
[TBL] [Abstract][Full Text] [Related]
9. Vitamin C enhances differentiation of a continuous keratinocyte cell line (REK) into epidermis with normal stratum corneum ultrastructure and functional permeability barrier.
Pasonen-Seppänen S; Suhonen TM; Kirjavainen M; Suihko E; Urtti A; Miettinen M; Hyttinen M; Tammi M; Tammi R
Histochem Cell Biol; 2001 Oct; 116(4):287-97. PubMed ID: 11702187
[TBL] [Abstract][Full Text] [Related]
10. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
Forsberg S; Ostman A; Rollman O
Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
[TBL] [Abstract][Full Text] [Related]
11. The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: correlation of increased expression with epidermal hyperplasia.
Hodak E; Gottlieb AB; Anzilotti M; Krueger JG
J Invest Dermatol; 1996 Mar; 106(3):564-70. PubMed ID: 8648195
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin.
Piazza GA; Ritter JL; Baracka CA
Exp Cell Res; 1995 Jan; 216(1):51-64. PubMed ID: 7813633
[TBL] [Abstract][Full Text] [Related]
13. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes.
Brennan D; Hu Y; Joubeh S; Choi YW; Whitaker-Menezes D; O'Brien T; Uitto J; Rodeck U; Mahoney MG
J Cell Sci; 2007 Mar; 120(Pt 5):758-71. PubMed ID: 17284515
[TBL] [Abstract][Full Text] [Related]
14. Epidermal EGFR controls cutaneous host defense and prevents inflammation.
Lichtenberger BM; Gerber PA; Holcmann M; Buhren BA; Amberg N; Smolle V; Schrumpf H; Boelke E; Ansari P; Mackenzie C; Wollenberg A; Kislat A; Fischer JW; Röck K; Harder J; Schröder JM; Homey B; Sibilia M
Sci Transl Med; 2013 Aug; 5(199):199ra111. PubMed ID: 23966300
[TBL] [Abstract][Full Text] [Related]
15. Effects of EGFR-TKI on epidermal melanin unit integrity: Therapeutic implications for hypopigmented skin disorders.
Xu P; Yang L; Lai S; Yang F; Kuroda Y; Zhang H; Tsuruta D; Katayama I
Pigment Cell Melanoma Res; 2024 Jul; 37(4):514-529. PubMed ID: 38705722
[TBL] [Abstract][Full Text] [Related]
16. Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model.
Gschwandtner M; Mildner M; Mlitz V; Gruber F; Eckhart L; Werfel T; Gutzmer R; Elias PM; Tschachler E
Allergy; 2013 Jan; 68(1):37-47. PubMed ID: 23157658
[TBL] [Abstract][Full Text] [Related]
17. Activation of kinin B receptor triggers differentiation of cultured human keratinocytes.
Matus CE; Ehrenfeld P; Pavicic F; Sarmiento JM; Astroza A; Sanchez T; Salem C; Concha M; Vidal MA; Gonzalez CB; Figueroa CD
Br J Dermatol; 2008 Sep; 159(4):792-803. PubMed ID: 18717683
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding epidermal-growth-factor-like growth factor activation of keratinocyte ErbB receptors Mediates epidermal hyperplasia, a prominent side-effect of retinoid therapy.
Varani J; Zeigler M; Dame MK; Kang S; Fisher GJ; Voorhees JJ; Stoll SW; Elder JT
J Invest Dermatol; 2001 Dec; 117(6):1335-41. PubMed ID: 11886492
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.
Chan KS; Carbajal S; Kiguchi K; Clifford J; Sano S; DiGiovanni J
Cancer Res; 2004 Apr; 64(7):2382-9. PubMed ID: 15059889
[TBL] [Abstract][Full Text] [Related]
20. EGFR regulation of epidermal barrier function.
Tran QT; Kennedy LH; Leon Carrion S; Bodreddigari S; Goodwin SB; Sutter CH; Sutter TR
Physiol Genomics; 2012 Apr; 44(8):455-69. PubMed ID: 22395315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
